Eli Lilly & Co. (LLY) Announces FDA Approval of Portrazza in NSCLC

November 24, 2015 2:42 PM
Eli Lilly & Co. (NYSE: LLY) announced today that the U.S. Food and Drug Administration (FDA) has approved Portrazza™ (necitumumab ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Corporate News FDA Management Comments

Next Articles